These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11813688)

  • 1. [Clinical and pharmacological studies of the second generation antipsychotics].
    Kuroki T; Tashiro N
    Fukuoka Igaku Zasshi; 2001 Nov; 92(11):365-9. PubMed ID: 11813688
    [No Abstract]   [Full Text] [Related]  

  • 2. [An introduction to antipsychotics].
    Takeuchi T; Nishikawa T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):165-8. PubMed ID: 12876956
    [No Abstract]   [Full Text] [Related]  

  • 3. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.
    Remington G; Kapur S
    J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses.
    Potvin S; Stip E; Roy JY
    Int Clin Psychopharmacol; 2003 May; 18(3):121-32. PubMed ID: 12702890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarities and differences among antipsychotics.
    Tamminga CA
    J Clin Psychiatry; 2003; 64 Suppl 17():7-10. PubMed ID: 14680420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment.
    Tarazi FI; Zhang K; Baldessarini RJ
    J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical antipsychotic drugs].
    Kahn RS
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.
    Kapur S; Seeman P
    Am J Psychiatry; 2001 Mar; 158(3):360-9. PubMed ID: 11229973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia, VI: Treatments.
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging roles for novel antipsychotic medications in the treatment of schizophrenia.
    Andersson C; Chakos M; Mailman R; Lieberman J
    Psychiatr Clin North Am; 1998 Mar; 21(1):151-79. PubMed ID: 9551495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bodyweight gain with atypical antipsychotics. A comparative review.
    Wetterling T
    Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
    Oerther S; Ahlenius S
    J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new antipsychotic compounds: is a clinical choice algorithm possible?
    Wirshing WC
    West J Med; 1998 Jul; 169(1):43-4. PubMed ID: 9682633
    [No Abstract]   [Full Text] [Related]  

  • 20. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.
    Schmidt AW; Lebel LA; Howard HR; Zorn SH
    Eur J Pharmacol; 2001 Aug; 425(3):197-201. PubMed ID: 11513838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.